{
    "2021-02-20": [
        [
            {
                "time": "2021-02-15",
                "original_text": "The Johnson & Johnson Vaccine Has Competition in the Race to Treat New Strains",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Vaccine",
                        "Competition",
                        "New Strains"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-15",
                "original_text": "Will AstraZeneca's Pain Be Johnson & Johnson's Gain?",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Pain",
                        "Johnson & Johnson",
                        "Gain"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}